Alexion Pharma (ALXN) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Income before income taxes: 169.97M
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Income before income taxes: 169.97M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Alexion Pharma (NASDAQ: ALXN) reported Q1 EPS of $1.11, $0.02 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $701 million versus the consensus estimate of $710.98 million.
For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Safe & Green (SGBX) Provides Update on Audit and Planned 10-K Filing
- Schlumberger (SLB) earnings in-line, revenue beats expectations
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
